VANCOUVER, BC, June 22, 2026 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics is headed to the prestigious 2026 Metals in Medicine Gordon Research Conference this week in Andover, New Hampshire. There,…
News provided by PR Newswire.














